홈MCP워크벤치Skills
홈워크벤치알림마이페이지
llms.txt · MCP 가이드개인정보처리방침 · 이용약관 · 지원v1.8.3
  1. 홈
  2. /화합물

Olopatadine Hydrochloride

HCID 5282402
새 반응
인쇄
기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
부분 구조 검색유사 구조 찾기

기본 정보

CAS
140462-76-6
표준 SMILES
CN(C)CC/C=C1/c2ccccc2COc2ccc(CC(=O)O)cc21.Cl
InChIKey
HVRLZEKDTUEKQH-NOILCQHBSA-N
분자식
C21H24ClNO3
평균 분자량
373.9 g/mol
단동위원소 질량
373.14447131

개요

Olopatadine hydrochloride is a dibenzooxazepine.

이름 및 식별자

우선 이름
Olopatadine Hydrochloride
IUPAC
2-[(11Z)-11-[3-(dimethylamino)propylidene]-6H-benzo[c][1]benzoxepin-2-yl]acetic acid;hydrochloride
영어명
Olopatadine hydrochloride
분자식
C21H24ClNO3
분자량
373.88

이름 및 동의어

OLOPATADINE HYDROCHLORIDE140462-76-6OLOPATADINE HClPatadayAllelockPatanasePazeoALO4943AKW4679DTXSID0046486KW-4679ALO-4943A
이름 더 보기
Olopatadin HCLOLAPATADINE HCLPatanolOlopatadine HydrochlordeDibenz[b,e]oxepin-2-acetic acid, 11-[3-(dimethylamino)propylidene]-6,11-dihydro-, hydrochloride (1:1), (11Z)-OpatanolAL-4943AOLOPATDINEHYDROCHLORIDE
Olopatadine (as hydrochloride)2XG66W44KFDTXCID8026486Dibenz(b,e)oxepin-2-acetic acid, 11-(3-(dimethylamino)propylidene)-6,11-dihydro-, hydrochloride, (Z)-RYALTRIS COMPONENT OLOPATADINE HYDROCHLORIDERetaine AllergyOnce Daily ReliefRefChem:56800

데이터베이스 식별자

CAS
140462-76-6
PubChem CID
5282402
DTXSID
DTXSID0046486
ChEMBL
CHEMBL1719
ChEBI
CHEBI:31933
UNII
2XG66W44KF
EC Number

물성

구조 계산 물성

극성 표면적
49.8 Ų
수소 결합 공여자 수
2
수소 결합 수용자 수
4
회전 가능 결합 수
5
무거운 원자 수
26
형식 전하
0
복잡도
488

실험 및 물리화학적 성질

Human Drugs · 3건

FDA approved drugs -> Active ingredient

EMA approved medicines: Human medicine

FDA approved drugs -> Active ingredient

물리화학적 성질

녹는점
242 · 242-245C
저장 조건
Inert atmosphere,Room Temperature
용해도
2 O: · H2O: ≥20mg/mL
물리적 상태
고체
색상
흰색에서 밝은 노란색
수용성
2 O: · H2O: ≥20mg/mL
Merck
14 · 14,6840
BCS Class
3 · 3(CLogP), 1 (LogP)
InChI
InChI=1S/C21H23NO3.ClH/c1-22(2)11-5-8-18-17-7-4-3-6-16(17)14-25-20-10-9-15(12-19(18)20)13-21(23)24;/h3-4,6-10,12H,5,11,13-14H2,1-2H3,(H,23,24);1H/b18-8-;
InChIKey
HVRLZEKDTUEKQH-NOILCQHBSA-N
SMILES
C(=C1/C2=CC=CC=C2COC2C=CC(CC(=O)O)=CC/1=2)\CCN(C)C.Cl

화학적 성질

White Solid

안전 및 규제

안전 정보는 참고용이며, 공급업체의 물질안전보건자료(SDS), 관련 법규 및 전문가 평가를 대체하지 않습니다.

GHS 분류

GHS Classification · 5건

This chemical does not meet GHS hazard criteria for 4.3% (2 of 47) of reports.

Danger

H301 (87.2%): Toxic if swallowed [Danger Acute toxicity, oral]

P264, P270, P273, P301+P316, P321, P330, P391, P405, and P501 (click each P-code to see the statement)

Aggregated GHS information provided per 47 reports by companies from 8 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.

유해성 정보

Hazard Classes and CategoriesAcute Tox. 3 (87.2%)

독성 정보

Exposure RoutesOphthalmic use of olopatadine usually does not produce measurable plasma concentrations.
Toxicity Summary · 1건

Olopatadine is a selective histamine H1 antagonist that binds to the histamine H1 receptor. This blocks the action of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine. Olopatadine is devoid of effects on alpha-adrenergic, dopamine and muscarinic type 1 and 2 receptors.

Signs and Symptoms · 1건

Its side effects may include headaches (7% of occurrence) burning and stinging (5%), dry eye, foreign body sensation, hyperemia, keratitis, lid edema, pruritus, asthenia, cold syndrome, pharyngitis, rhinitis, sinusitis, and taste perversion. [Wikipedia]

Carcinogen ClassificationNo indication of carcinogenicity to humans (not listed by IARC).

안전 데이터

화학 및 산업

약리 정보

Metabolism/MetabolitesThe mono-desmethyl and the N-oxide metabolites have been detected at low concentrations in the urine. Route of Elimination: Elimination was predominantly through renal excretion. Half Life: 3 hours
FDA Pharmacological Classification · 6건

OLOPATADINE HCL

Decreased Histamine Release [PE]; Mast Cell Stabilizer [EPC]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Histamine H1 Receptor Antagonists [MoA]

OLOPATADINE HYDROCHLORIDE

Mast Cell Stabilizer [EPC]; Decreased Histamine Release [PE]; Histamine-1 Receptor Antagonist [EPC]; Histamine H1 Receptor Antagonists [MoA]; Histamine-1 Receptor Inhibitor [EPC]

OLOPATADINE HYDROCHLORIDE OPHTHALMIC

Decreased Histamine Release [PE]; Mast Cell Stabilizer [EPC]; Histamine-1 Receptor Antagonist [EPC]; Histamine-1 Receptor Inhibitor [EPC]; Histamine H1 Receptor Antagonists [MoA]

MeSH Pharmacological Classification · 3건

Anti-inflammatory agents that are non-steroidal in nature. In addition to anti-inflammatory actions, they have analgesic, antipyretic, and platelet-inhibitory actions. They act by blocking the synthesis of prostaglandins by inhibiting cyclooxygenase, which converts arachidonic acid to cyclic endoperoxides, precursors of prostaglandins. Inhibition of prostaglandin synthesis accounts for their analgesic, antipyretic, and platelet-inhibitory actions; other mechanisms may contribute to their anti-inflammatory effects.

Agents that are used to treat allergic reactions. Most of these drugs act by preventing the release of inflammatory mediators or inhibiting the actions of released mediators on their target cells. (From AMA Drug Evaluations Annual, 1994, p475)

A class of non-sedating drugs that bind to but do not activate histamine receptors (DRUG INVERSE AGONISM), thereby blocking the actions of histamine or histamine agonists. These antihistamines represent a heterogenous group of compounds with differing chemical structures, adverse effects, distribution, and metabolism. Compared to the early (first generation) antihistamines, these non-sedating antihistamines have greater receptor specificity, lower penetration of BLOOD-BRAIN BARRIER, and are less likely to cause drowsiness or psychomotor impairment.

관련 반응

2건
반응 기록 만들기
HRID 422887 반응식
HRID 422887반응물로
HRID 2247135 반응식
HRID 2247135생성물로

화합물 노트

이 페이지에서기본 정보개요이름 및 식별자물성안전 및 규제화학 및 산업관련 반응화합물 노트
604-185-4
wgk
3
rtecs
HQ4135060
ridadr
UN 2811 6.1 / PGIII
HS 번호
29329990
risk_code
25-50
hazard_code
T,N
safety_code
45-61
Hazard Classifications
Acute Tox. 3 OralAquatic Acute 1
스토리지 클래스
6.1C - Combustible acute toxic Cat.3toxic compounds or compounds which causing chronic effects

용도 및 제조

UsesFor the treatment of ocular itching associated with allergic conjunctivitis. Used as an antihistamine. [Wikipedia]
응용 분야 · 2건

개요Olopatadine hydrochloride is an ophthalmic antihistamine that inhibits release of histamine from mast cells and is a relatively selective histamine H1 antagonist. It inhibits type 1 immediate hypersensitivity reactions. Olopatadine hydrochloride is indicated in the temporary relief of itching caused by allergic conjunctivitis. H1 antagonists have an established and valued place in the symptomatic treatment of various immediate hypersensitivity reactions. In addition, the central properties of some of the series are of therapeutic value for suppressing motion sickness or for sedation.

용도Olopatadine hydrochloride is a potent, selective antagonist of the H1 histamine receptor (Ki = 16-41.1 nM), with much lower affinities for the H2 and H3 receptors (Ki = 43.4 and 172 μM, respectively). It blocks histamine-induced phosphoinositide turnover in isolated cells (IC50 = 9.5-39.9 nM) and prevents passive cutaneous anaphylaxis in rats (ED50 = 49 μg/kg) and anaphylactic bronchoconstriction in guinea pigs (ID50 = 30 μg/kg). Olopatadine is effective in treating allergic rhinitis and conjunctivitis. It also suppresses itch in patients with well-controlled chronic urticaria. In humans, this antihistamine does not cause cognitive or psychomotor impairment at therapeutic doses.[Cayman Chemical]

상·하류 제품 정보

상류 원료

Olopatadine Ethyl Ester[3-(Dimethylamino)propyl]triphenylphosphonium bromide hydrobromide3-((디메틸아미노)프로필)트리페닐포스포늄브로마이드OlopatadineIsoxepacUGDFSHGFPJSALM-OCKHKDLRSA-N클로로[3-(디메틸아미노)프로필]마그네슘3-클로로프로필(디메틸)아민

하류 제품

(E)-올로파타딘염산염